Thursday, March 14, 2013

Maureen Donovan, PhD, received an award from the National Institute for Pharmaceutical Technology and Education (NIPTE) as part of an FDA U01 project.  Her proposal “Pediatric Nasal Dosage Forms: In Vitro Characterization of Intranasal Deposition Patterns in Children for Optimal Delivery and Performance” was chosen by the FDA in the Open Proposals review area.